Report overview
Infectious Disease Drugs are drugs that relieve symptoms, resolve symptoms, or block the route of transmission.
This report contains market size and forecasts of Infectious Disease Drugs in Global, including the following market information:
Global Infectious Disease Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Infectious Disease Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Antibacterials Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Infectious Disease Drugs include GlaxoSmithKline, Gilead Sciences, Merck & Co., Pfizer, Sanofi, AbbVie, Shire, Grifols and Johnson & Johnson, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Infectious Disease Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Infectious Disease Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Infectious Disease Drugs Market Segment Percentages, by Type, 2021 (%)
Antibacterials
Antiviral drugs
Antiparasitic drugs
Antifungal
Others
Global Infectious Disease Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Infectious Disease Drugs Market Segment Percentages, by Application, 2021 (%)
HIV
Malaria
Hepatitis
Influenza
HPV
Tuberculosis
Others
Global Infectious Disease Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Infectious Disease Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Infectious Disease Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Infectious Disease Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Gilead Sciences
Merck & Co.
Pfizer
Sanofi
AbbVie
Shire
Grifols
Johnson & Johnson
Protein Sciences
AstraZeneca
